Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. PRYMY
3. SPY
4. SKA-B
5. PBA
6. ALAR
7. CCH:LN
8. META
9. CCHGY
10. PRY:IM

Go back to Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
(NASDAQ: HELP) Delayed: 6.24 -0.04 (0.64%)
Previous Close $6.28    52 Week High $ 
Open $6.23    52 Week Low $ 
Day High $6.51    P/E N/A 
Day Low $6.16    EPS $ 
Volume 909,920